ArticleBioinformation2026
Andes virus and sin nombre virus: Similarities and distinctive features.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The threat of hanta virus infection has come to the forefront in recent weeks, following the outbreak of the Andes virus aboard the Dutch-flagged MV Hondius cruise ship during its spring 2026 voyage. Several passengers and crew members got infected because Andes virus is the sole known hanta virus to trigger human-to-human infection. All exposed passengers have returned to their countries in Asia, the Americas and Europe, and remain in quarantine to this day because of Andes virus extended incubation period (35-45 days). Several infected patients have died due to Andes high mortality (35-50%). Taken together, the unfolding of these alarming facts has ignited fears of a new hanta virus pandemic. Here, we briefly outline certain among the major similarities and distinctive features between Andes virus and Sin Nombre virus, the two principal hanta viruses known today to infect humans. This writing emphasizes how timely and critical it is to develop concerted research and accelerated testing programs for anti-hanta virus vaccines and antivirals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.